Hepatocellular carcinoma chemoembolization therapeutic. Medical search. Frequent questions

The purpose of our study was to assess the value of coded phase-inversion harmonic sonography performed approximately 1 week after the patients had undergone transcatheter arterial chemoembolization with iodized oil for hepatocellular carcinoma. (nih.gov)
We studied 40 patients with 44 nodules measuring 1.5-11.0 cm in diameter (mean +/- SD, 3.9 +/- 2.0 cm) who underwent transcatheter arterial chemoembolization. (nih.gov)
Of 19 nodules of hepatocellular carcinoma treated only by transcatheter arterial chemoembolization, 17 nodules showed enhancement on coded phase-inversion harmonic sonography, suggesting incomplete responses. (nih.gov)
Transcatheter arterial chemoembolization (TACE) via the inferior phrenic artery has been recognized to have its own therapeutic role without causing serious procedural complications. (biomedcentral.com)
Transcatheter arterial chemoembolization (TACE) is a standard locoregional treatment for intermediate-stage hepatocellular carcinoma (HCC) [ 1 ]. (biomedcentral.com)
Transcatheter arterial chemoembolization (TACE) via the right inferior phrenic artery. (biomedcentral.com)
To clarify the hemodynamic changes under balloon occlusion of the hepatic artery and to identify predictors of the short-term therapeutic effect (TE) after balloon-occluded transcatheter arterial chemoembolization using miriplatin (B-TACE) for hepatocellular carcinoma (HCC). (springeropen.com)
CoCl2 was used in rat liver tumor cell line McA RH-7777 to stimulate hypoxia to mimic the hypoxic conditions induced by transcatheter arterial chemoembolization (TACE). (elis.sk)
Combined SBRT and immunotherapy resulted in significantly superior survival and less toxicity compared with transcatheter arterial chemoembolization (TACE) [ 14 ]. (biomedcentral.com)
These include direct ablation of the tumour using agents such as ethanol or acetic acid, transcatheter arterial chemoembolization, or systemic chemotherapy. (ox.ac.uk)
Transcatheter arterial chemoembolization may be used as an interim treatment for patients waiting for OLT. (elsevierpure.com)
The mix of transcatheter arterial chemoembolization and sorafenib is well tolerated and effective in Asian patients with hepatocellular carcinoma: remaining outcomes of the BEGIN trial. (page.tl)

We retrospectively evaluated the long-term effects of partial splenic embolization (PSE) with transarterial chemoembolization (TACE) in patients with HCC patients accompanied by thrombocytopenia. (hindawi.com)
Since cirrhotic patients with severe thrombocytopenia are at greater risk for bleeding, treatments against HCC such as liver transplantation, resection, local ablation therapy, and transarterial chemoembolization (TACE) can be performed following a platelet transfusion in those patients. (hindawi.com)
This review summarizes the different IR treatment options in HCC, including various ablative therapies, Transarterial Chemoembolization (TACE), Transarterial Radioembolization (TARE), Portal Vein embolization, emphasizing patient selection, procedural considerations and response evaluation. (thieme-connect.de)
Aim: To perform a quantitative, volumetric analysis of therapeutic effects of trans-arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC) patients. (uni-koeln.de)
Conclusion: Quantification of therapeutic changes after TACE therapy is feasible using a semi-automated segmentation and evaluation tool. (uni-koeln.de)
To evaluate the effectiveness of transarterial chemoembolization (TACE) combined with lenvatinib and sintilimab in treating patients with midstage hepatocellular carcinoma (HCC). (hindawi.com)
TACE combined with lenvatinib and sintilimab in the treatment of Barcelona Clinic Liver Cancer (BCLC) stage B hepatocellular carcinoma can effectively control the tumor progression and prolong the survival time of patients. (hindawi.com)
At present, both the European Association for the Study of the Liver (EASL) [ 2 ] and the American Association for the Study of Liver Diseases (AASLD) [ 3 ] recommend transarterial chemoembolization (TACE) as the standard treatment option for patients with intermediate-stage (BCLC stage B) HCC. (hindawi.com)
Arterial chemoembolization is also termed transarterial chemoembolization (TACE). (medscape.com)
Background To determine the safety and efficacy of transarterial chemoembolization (TACE) combined with radiofrequency ablation (hereafter, TACE-RFA) in treating Barcelona Clinic Liver Cancer (BCLC) Stage A or B (hereafter, BCLC A/B) hepatocellular carcinoma (HCC) patients, and to explore the range of tumor sizes suitable for combination therapy. (researchsquare.com)
In recent years, transarterial chemoembolization (TACE) as a palliative therapy has been recognized as the standard method for patients with unresectable HCC [11,12]. (researchsquare.com)
Our findings showed that HIF-1α play an important role in the stimulation of the secreted VEGF expression under hypoxic conditions, suggesting that targeting both HIF-1α and VEGF could represent a potential therapeutic strategy in combination with TACE in the treatment of liver tumors. (elis.sk)
We investigated the outcomes of early-stage hepatocellular carcinoma (HCC) patients who showed a complete response (CR) to initial transarterial chemoembolization (TACE), with a focus on the role of scheduled TACE repetition. (e-cmh.org)
Transarterial chemoembolization (TACE) is the most commonly used nonsurgical treatment modality for patients with hepatocellular carcinoma (HCC) [ 1 ]. (e-cmh.org)
Transarterial chemoembolization (TACE) and sorafenib are the therapeutic standard for intermediate and advanced stage hepatocellular carcinoma (HCC) patients respectively. (pharmafocusasia.com)
TACE was performed during and after sorafenib discontinuation and therapeutic response bimonthly to four-monthly was rated thereafter. (pharmafocusasia.com)
Therefore, other therapeutic modalities to improve the survival of such patients are being tried, including surgical resection, transarterial chemoembolization (TACE), chemotherapy, and three-dimensional conformal radiotherapy, but the clinical outcomes remain unsatisfactory. (biomedcentral.com)
The aim of this retrospective multicentric study was to compare the tumour response rates of Balloon-occluded Transarterial Chemoembolisation (B-TACE) to non-B-TACE using propensity score matching (PSM) in patients with hepatocellular carcinoma and to investigate the clinical benefit, such as lower rates of TACE re-intervention achieved using B-TACE. (springer.com)
Also included will be trans-arterial chemoembolization (TACE) and Sorafenib for patients with intermediate and advanced-stage cancer, respectively. (alquds.edu)

12]RIAZ A,MILLER FH,KULIK LM,et al.Imaging response in the primary index lesion and clinical outcomes following transarterial locoregional therapy for hepatocellular carcinoma[J].JAMA,2010,303(11):1062-1069. (lcgdbzz.org)
14]GILLMORE R,STUART S,KIRKWOOD A,et al.EASL and mRECIST responses are independent prognostic factors for survival in hepatocellular cancer patients treated with transarterial embolization[J].J Hepatol,2011,55(6):1309-1316. (lcgdbzz.org)
16]JUNG ES,KIM JH,YOON EL,et al.Comparison of the methods for tumor response assessment in patients with hepatocellular carcinoma undergoing transarterial chemoembolization[J].J Hepatol,2013,58(6):1181-1187. (lcgdbzz.org)
Even local therapies, such as transarterial chemoembolization, find limited indications, leading to an important problem regarding treatment of advanced disease. (unifi.it)
For those with intermediate, or stage B, disease, the panel says patients should receive transarterial chemoembolization as first-line therapy and recommend against the use of adjuvant sorafenib. (medscape.com)
Prediction of Early Treatment Response to Initial Conventional Transarterial Chemoembolization Therapy for Hepatocellular Carcinoma by Machine-Learning Model Based on Computed Tomography. (cdc.gov)

There is currently no widely-accepted consensus for the management of hepatocellular carcinoma with portal vein tumor thrombus. (biomedcentral.com)
2] BRUIX J,SHERMAN M,American Association for the Study of Liver Diseases.Management of hepatocellular carcinoma:an update[J].Hepatology,2011,53(3):1020-1022. (lcgdbzz.org)
3]European Association for the Study of the Liver,European Organisation for Research and Treatment of Cancer.EASL-EORTC clinical practice guidelines:management of hepatocellular carcinoma[J].J Hepatol,2012,56(4):908-943. (lcgdbzz.org)
8]BRUIX J,SHERMAN M,LLOVET JM,et al.Clinical management of hepatocellular carcinoma.Conclusions of the Barcelona-2000 EASL conference.European Association for the Study of the Liver[J].J Hepatol,2001,35(3):421-430. (lcgdbzz.org)
Rust, C & Gores, GJ 2001, ' Locoregional management of hepatocellular carcinoma: Surgical and ablation therapies ', Clinics in liver disease , vol. 5, no. 1, pp. 161-173. (elsevierpure.com)

Drug-eluting beads trans-arterial chemoembolization for leiomyosarcoma, liver metastases from colorectal cancer, and for primary and liver-dominant metastatic disease of the liver. (aetna.com)
Trans-arterial radioembolization (TARE) is a recognized, although not explicitly recommended, experimental therapy for unresectable hepatocellular carcinoma (HCC). (oncotarget.com)
Additionally, it can be used to treat larger tumors (>3cm) as it is not associated the same size limitations as ablative techniques and can also be utilized to treat lesions that are not amenable to intra-arterial therapies (such as trans-arterial chemoembolization and yttrium-90 radioembolization). (survivornet.com)

High costs with adverse events (AE) of sorafenib might limit sorafenib dosage, further affecting therapeutic response. (pharmafocusasia.com)
Sorafenib is a multitargeted tyrosine kinase inhibitor (TKI) of tumor cell proliferation and angiogenesis used to deal with patients with superior clear cell renal cell carcinoma. (page.tl)
Sorafenib is a multikinase inhibitor that has just lately obtained Meals and Drug Administration (FDA) approval for the remedy of advanced renal cell carcinoma (RCC). (page.tl)
Recent trials in adults have demonstrated the efficacy of tyrosine kinase inhibitors like sorafenib in patient with locally advanced hepatocellular carcinoma. (medscape.com)
This article briefly introduces the development of response evaluation criteria for tumors,elaborates on the application of radiological evaluation criteria in local interventional therapy or sorafenib treatment of hepatocellular carcinoma( HCC),compares the four radiological evaluation criteria,i. e. (lcgdbzz.org)
17]EDELINE J,BOUCHER E,ROLLAND Y,et al.Comparison of tumor response by response evaluation criteria in solid tumors(RECIST)and modified RECIST in patients treated with sorafenib for hepatocellular carcinoma[J].Cancer,2012,118(1):147-156. (lcgdbzz.org)
18]RONOT M,BOUATTOUR M,WASSERMANN J,et al.Alternative response criteria(Choi,European association for the study of the liver,and modified response evaluation criteria in solid tumors[RECIST])versus RECIST 1.1 in patients with advanced hepatocellular carcinoma treated with sorafenib[J].Oncologist,2014,19(4):394-402. (lcgdbzz.org)
Sorafenib remains one major first-line therapeutic options for advanced hepatocellular carcinoma (aHCC), with modest efficacy. (nature.com)
Due to this fact, the overall therapeutic response of sorafenib for sufferers with superior HCC may be higher mirrored by the treatment duration as an alternative of whole dosage in this study. (page.tl)
In the first-line setting, Su and colleagues recommend atezolizumab (Tecentriq) plus bevacizumab (Avastin) over the previous therapeutic standby, sorafenib (Nexavar), in patients with advanced HCC and preserved liver function. (medscape.com)

We also evaluated the recurrence of hepatocellular carcinoma during clinical follow-up in 17 patients who did not undergo additional local therapy. (nih.gov)
We found coded phase-inversion harmonic sonography to be highly sensitive and accurate for evaluating the treatment response in patients with hepatocellular carcinoma even shortly after treatment. (nih.gov)
Thrombocytopenia often makes the introduction of systemic treatment difficult in patients with cirrhosis and hepatocellular carcinoma (HCC). (hindawi.com)
Hepatocellular carcinoma (HCC) frequently develops in patients with cirrhosis. (hindawi.com)
Radio frequency ablation for hepatocellular carcinoma in cirrhotic patients: prognostic factors for survival. (thieme-connect.de)
Radio-frequency ablation in cirrhotic patients with hepatocellular carcinoma. (thieme-connect.de)
Final diagnoses based on histological findings were pancreatic ductal carcinomas in 49 patients, inflammatory pseudotumours with chronic pancreatitis in seven, and endocrine tumours in nine. (bmj.com)
In this study, we aimed to compare the radiation-induced hepatic toxicity (RIHT) outcomes of radiotherapy (RT) plus antibodies against programmed cell death protein 1 (anti-PD1) versus RT alone in patients with hepatocellular carcinoma (HCC), evaluate prognostic factors of non-classic radiation-induced liver disease (ncRILD), and establish a nomogram for predicting the probability of ncRILD. (biomedcentral.com)
In patients with hepatocellular carcinoma not amenable to surgical intervention a variety of different therapeutic interventions have been investigated. (ox.ac.uk)
Chemoembolization into isolated branches of the hepatic artery may benefit patients with nonmetastatic but unresectable or recurrent tumor. (medscape.com)
15]SHIM JH,LEE HC,KIM SO,et al.Which response criteria best help predict survival of patients with hepatocellular carcinoma following chemoembolization?A validation study of old and new models[J].Radiology,2012,262(2):708-718. (lcgdbzz.org)
In this study, we developed a novel prognostic model for hepatocellular carcinoma based on cuproptosis-related genes that can effectively predict the prognosis of LIHC patients. (biomedcentral.com)
All patients with localized HCC (involvement of one single lobe, no vascular invasion or extrahepatic disease) should be evaluated for the potentially curative therapeutic options of partial hepatectomy or OLT. (elsevierpure.com)
The future of the treatment of this neoplasia is linked to our ability to understand its mechanisms of resistance and to find novel therapeutic targets, with the objective to purpose individualized approaches to patients affected by advanced HCC. (unifi.it)
Hepatocellular carcinoma (HCC) is a primary malignancy of the liver and occurs predominantly in patients with underlying chronic liver disease and cirrhosis. (medscape.com)
In these patients, local ablative therapies, including radiofrequency ablation (RFA), chemoembolization, and potentially novel chemotherapeutic agents, may extend life and provide palliation. (medscape.com)
Only patients with advanced hepatocellular carcinoma (HCC) and preserved liver function should receive systemic therapies, according to new clinical practice guidelines from the American Gastroenterological Association. (medscape.com)
Therefore, the miR‑197‑3p/ZIK1 axis may serve as a novel therapeutic target in patients with HCC. (spandidos-publications.com)
Ashmawy AM, Elgeshy KM, Abdel Salam ET, Ghareeb M, Kobaisi MH, Amin HAA, Sharawy SK and Abdel Wahab AHA: Crosstalk between liver-related microRNAs and Wnt/β-catenin pathway in hepatocellular carcinoma patients. (spandidos-publications.com)
Hepatectomy is an effective treatment for selected patients with large hepatocellular carcinoma (HCC). (xiahepublishing.com)
Indications for pancreatoduodenectomy in patients undergoing lymphadenectomy for advanced gallbladder carcinoma. (cancercentrum.se)

Key predictors of tumor response after chemoembolization on unresectable HCC include tumor size, vascularity, and number, as well as portal vein invasion. (medscape.com)
Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial. (jcimjournal.com)

Liver abscess after percutaneous radiofrequency ablation for hepatocellular carcinomas: frequency and risk factors. (thieme-connect.de)
Complications of percutaneous radiofrequency ablation for hepato-cellular carcinoma: imaging spectrum and management. (thieme-connect.de)

Le Grazie M, Biagini MR, Tarocchi M, Polvani S, Galli A. Chemotherapy for hepatocellular carcinoma: The present and the future. (wjgnet.com)

In all 17 nodules, apparent recurrence was noted on dynamic CT during clinical follow-up, even in nodules that had been observed to be completely filled with iodized oil 1 week after the chemoembolization. (nih.gov)
Consequently, it allows early recognition of the need for additional local ablation therapy and estimation of the risk of hepatocellular carcinoma recurrence. (nih.gov)
Compared with this, liver transplantation is a potentially ideal treatment because it can also treat the background liver, eliminate the possibility of metachronous multicentric recurrence and does not leave micro-carcinoma in the residual Ceritinib liver because the diseased liver is completely resected. (hormonessignaling.com)
Hepatocellular carcinoma (HCC) is an aggressive disease with high recurrence rate. (e-crt.org)
Yoo S, Wang W, Wang Q, Fiel MI, Lee E, Hiotis SP and Zhu J: A pilot systematic genomic comparison of recurrence risks of hepatitis B virus-associated hepatocellular carcinoma with low- and high-degree liver fibrosis. (spandidos-publications.com)
Factors influencing recurrence after surgical treatment for T2 gallbladder carcinoma. (cancercentrum.se)

The patient was diagnosed with double primary hepatic cancer (hepatocellular carcinoma and intrahepatic cholangiocarcinoma) and underwent partial liver hepatectomy and cholecystectomy. (biomedcentral.com)

11]FORNER A,AYUSO C,VARELA M,et al.Evaluation of tumor response after locoregional therapies in hepatocellular carcinoma:are response evaluation criteria in solid tumors reliable? (lcgdbzz.org)
These studies have demonstrated the feasibility, safety, and clinical effectiveness of this method, establishing it as a therapeutic option when use of thermal ablation therapies is restricted. (survivornet.com)

Since the term chemoembolization does not appear in the title, abstract, or any other field, prior to when this citation was indexed for MEDLINE it would be missed by a search for chemoembolization and hepatocellular carcinoma. (mssm.edu)

We evaluate the safety and efficacy of ultrasound-guided percutaneous brachytherapy with iodine-125 seeds for the treatment of hepatocellular carcinoma with portal vein-branch tumor thrombus (PVBTT). (biomedcentral.com)
The efficacy and safety of these therapeutic measures in children remains to be determined. (medscape.com)

Hepatocellular carcinoma (HCC) is a vascular tumour with poor prognosis. (nature.com)
However, the role of miR‑197‑3p in the progression and prognosis of hepatocellular carcinoma (HCC) remains unknown. (spandidos-publications.com)
In the United States, 80%-90% of primary hepatic tumors are hepatocellular carcinomas and 10%-15% are cholangiocarcinomas (CCA), both with high mortality rate, particularly CCA, which portends a worse prognosis. (wjgnet.com)

Finally, this review article discusses the present therapeutic and treatment options for HCC such as resection, transplantation, or ablation used to treat early stage cancer. (alquds.edu)

Ye JZ, Wang YY, Bai T, Chen J, Xiang BD, Wu FX and Li LQ: Surgical resection for hepatocellular carcinoma with portal vein tumor thrombus in the Asia-Pacific region beyond the Barcelona Clinic Liver Cancer treatment algorithms: A review and update. (spandidos-publications.com)

13]MEMON K,KULIK L,LEWANDOWSKI RJ,et al.Radiographic response to locoregional therapy in hepatocellular carcinoma predicts patient survival times[J].Gastroenterology,2011,141(2):526-535. (lcgdbzz.org)

Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide and its incidence is on the rise. (thieme-connect.de)
Hepatocellular carcinoma accounts for 70-90% of primary liver cancers, and the incidence of HCC in the United States has tripled over the past 4 decades, which has been attributed to a number of factors, such as undiagnosed chronic hepatitis C virus, alcohol consumption, and increased levels of obesity and metabolic syndrome. (medscape.com)
Aetna considers percutaneous ethanol injection (PEI) medically necessary for the treatment of hepatocellular cancers (HCC) without extra-hepatic spread. (aetna.com)
Liver cancer is the third leading cause of cancer-associated mortality, of which hepatocellular carcinoma (HCC) represents 90% of all primary liver cancers. (wjgnet.com)
Primary liver cancers are divided into hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma (ICC), and combined hepatocellular carcinoma and cholangiocarcinoma (cHCC-CC) according to the histological type. (biomedcentral.com)
The Cdk5-AMT signal pathway involved in regulation of DDR by TIGAR defines a new role of TIGAR in cancer cell survival and it suggests that TIGAR may be a therapeutic target for cancers. (nature.com)

The treatment of choice for hepatocellular carcinoma remains surgical resection or liver transplantation, in carefully selected cases. (ox.ac.uk)
Unfortunately, complete surgical resection of hepatocellular carcinoma (HCC) is possible in fewer than 30% of children at diagnosis. (medscape.com)

Confirming portal vein patency is important because portal vein thrombosis is a relative contraindication to chemoembolization. (medscape.com)

By contrast, therapeutic IR procedures provide direct treatment-they include catheter-based medicine delivery, medical device placement (e.g., stents), and angioplasty of narrowed structures. (wikipedia.org)
Chemoembolization (CE) for other indications including palliative treatment of liver metastases from other non-neuroendocrine primaries (e.g., breast cancer, cervical cancer, colon cancer, esophageal cancer, melanoma, rhabdomyosarcoma, or unknown primaries) and CE of the pancreas for pancreatic cancer. (aetna.com)
Immunotherapy with dendritic cells and/or cytokine-induced killer cells for the treatment of hepatocellular carcinoma. (aetna.com)
An early and accurate response evaluation is essential for clinicians to decide whether to continue the treatment with current therapeutic regimen or to make necessary changes. (lcgdbzz.org)
This research aimed to in vivo illustration of 1,3,4-oxadiazole-2-thiol (OXD-T) anticancer activities as a discovery of the treatment of Hepatocellular Carcinoma (HCC) of Albino rats. (walshmedicalmedia.com)
The post treatment of HCC induced rats was carried out with OXD-T therapeutic (300 mg/kg. (walshmedicalmedia.com)
OXD-T therapeutic administration revealed highly significant decreases in the biochemical values and DNA fragmentation parameters more than half dose of OXD-T treatment. (walshmedicalmedia.com)
Despite the spread of HCC, its treatment it's still a hard challenge, due to high rate of late diagnosis and to lack of therapeutic options for advanced disease. (unifi.it)

Pre-operative hepatic artery chemoembolization followed by orthotopic liver transplantation for HCC. (aetna.com)

[ 11 ] Conventional and drug-eluting bead chemoembolization have been found to have a limited impact on liver function, and tumor response is not dependent on type of embolization used. (medscape.com)
Angiography is an essential part of the workup performed before embolization or chemoembolization, although most centers proceed to the embolization procedure if no contraindications are present. (medscape.com)

Application of anti-PD-1/PD-L1 antibodies as checkpoint inhibitors is rapidly becoming a promising therapeutic approach in treating tumors, and some of them have successfully been commercialized in the past few years [ 10 ]. (hindawi.com)
Hepatocellular carcinoma (HCC) is still one of the most common tumors in the world and the second most common cause of cancer death [1,2]. (researchsquare.com)
Carcinoid tumors and small-cell carcinomas of the gallbladder and extrahepatic bile ducts: a comparative study based on 221 cases from the Surveillance, Epidemiology, and End Results Program. (cancercentrum.se)

Synchronous development of primary hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC) in different sites of the liver have rarely been reported before. (biomedcentral.com)
Each year, approximately 2500 cases of cholangiocarcinoma occur, compared with 5000 cases of gallbladder cancer and 15,000 cases of hepatocellular cancer. (medscape.com)

Progression-free survival (PFS), overall survival (OS), therapeutic response, and complications were compared between the two groups. (researchsquare.com)

4]LLOVET JM,DI BISCEGLIE AM,BRUIX J,et al.Design and endpoints of clinical trials in hepatocellular carcinoma[J].J Natl Cancer Inst,2008,100(10):698-711. (lcgdbzz.org)

Hepatic resection in 485 R0 pT2 and pT3 cases of advanced carcinoma of the gallbladder: results of a Japanese Society of Biliary Surgery survey--a multicenter study. (cancercentrum.se)

In fact radical surgery and liver transplantation, the most radical therapeutic approaches, are indicated only in case of early diagnosis. (unifi.it)

Liver hepatocellular carcinoma (LIHC) is one of the most common malignancies worldwide, ranking as the sixth most common type of cancer globally [ 1 ]. (biomedcentral.com)

OXD-T antimetabolite with different therapeutic doses of administration affected the growth of hepatocellular carcinoma. (walshmedicalmedia.com)

IR performs both diagnostic and therapeutic procedures through very small incisions or body orifices. (wikipedia.org)
Skin Electrical Resistance as a Diagnostic and Therapeutic Biomarker of Breast Cancer Measuring Lymphatic Regions. (cdc.gov)

Novikova MV, Khromova NV and Kopnin PB: Components of the hepatocellular carcinoma microenvironment and their role in tumor progression. (spandidos-publications.com)

In studies using auto-tracking contrast quantification software, the time to peak, the contrast-enhanced time, and the wash-out time were longer for well-differentiated hepatocellular lesions, and the enhancement slope and clearance slope were lower than that of moderately to poorly differentiated carcinomas. (medscape.com)

Hepatocellular carcinoma (HCC) is the sixth most commonly diagnosed and fourth most lethal neoplasm worldwide. (hindawi.com)
Hepatocellular carcinoma (HCC) is the sixth most common cancer of men and eleventh most common cancer of women world-wide. (ox.ac.uk)
Hepatocellular carcinoma (HCC) is the sixth most common cancer and the third most prevalent cause of cancer-related death worldwide [ 1 ]. (biomedcentral.com)
Liver hepatocellular carcinoma (LIHC) ranks sixth among the most common types of cancer with a high mortality rate. (biomedcentral.com)

Should the extrahepatic bile duct be resected or preserved in R0 radical surgery for advanced gallbladder carcinoma? (cancercentrum.se)

Anatomy10

Organisms6

Diseases61

Chemicals and Drugs45

Analytical, Diagnostic and Therapeutic Techniques and Equipment67

Phenomena and Processes26

Disciplines and Occupations1

Technology, Industry, Agriculture1

Information Science6

Health Care26

Geographicals2

Transcatheter arterial chemoemb12

TACE19

Transarterial6

Management of hepatocellular carcinoma5

Trans-arterial3

Sorafenib10

Patients21

Unresectable2

Radiofrequency ablation2

Chemotherapy1

Recurrence6

Hepatectomy1

Therapies2

Abstract1

Efficacy2

Prognosis3

Ablation1

Barcelona Clinic Liver Cancer1

Locoregional1

Cancers6

Surgical2

Portal Vein1

Treatment8

Hepatic artery1

Embolization2

TUMORS3

Cholangiocarcinoma2

Survival1

Clinical1

Resection1

Diagnosis1

Malignancies1

Different therapeutic1

Diagnostic2

Tumor progression1

Lesions1

Sixth4

Gallbladder1